Tesla (TSLA) shares fell in early trading following a Wall Street Journal report that CEO Elon Musk's illegal drug use has worried Tesla executives and board members. Musk denied the report, saying he is subjected to random drug testing by NASA. Yahoo Finance’s Seana Smith and Brad Smith discuss the latest report and potential impact on shareholders. Not exactly something that they're unfamiliar with, trying to dealing with some of these side reporting and exactly how it's impacting CEO Elon Musk. We know a lot of the hype and a lot of excitement surrounding Tesla is tied directly to CEO Elon Musk and his vision there for the company.

Source: Wall Street Journal January 08, 2024 17:30 UTC